This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Gachon University of Industry-Academic Cooperation Foundation, Gil Medical Center. Active years: 2025.
Company Filing History:
1 out of 70 
1 out of 24 Years Active: 2025
Title: Shi-Young Park: Innovator in Pharmaceutical Compounds
Introduction
Shi-Young Park is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Shi-Young Park holds a patent for a novel 4-carbonylamino-4-phenylpyrimidine compound or a pharmaceutically acceptable salt thereof. This invention relates to a compound that exhibits GDH activity, making it effective for the prevention or treatment of obesity, diabetes, or fatty liver. He has 1 patent to his name, showcasing his innovative approach to addressing critical health issues.
Career Highlights
Throughout his career, Shi-Young Park has been associated with prominent institutions such as Gachon University of Industry-Academic Cooperation Foundation and Gil Medical Center. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Shi-Young Park has collaborated with notable colleagues, including Dongyun Shin and Cheol Soo Choi. These partnerships have likely enriched his research and expanded the impact of his inventions.
Conclusion
Shi-Young Park's contributions to pharmaceutical innovation highlight his commitment to addressing significant health challenges. His work continues to inspire advancements in the field of medicine.